Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis ...

Immunoprecipitation-enhanced blood-based biomarkers are improving early diagnosis of Alzheimer’s disease by enabling more ...

The world’s first AI-based optical diagnostic platform offers potential for near-instant diagnosis of CSF rhinorrhea.

INDIANAPOLIS, June 27, 2023 /PRNewswire/ -- Roche today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys ® Total-Tau CSF assays (tTau) have received U.S. Food and Drug ...

A novel blood and cerebrospinal fluid (CSF) measure showed promise as a biomarker for Parkinsonian disorders. CSF levels of DOPA decarboxylase (DDC) -- an enzyme that converts levodopa into dopamine - ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

These biomarker changes occurred alongside clinical stabilization or improvement, with no serious treatment-related adverse events.

For many years, scientists have searched for the cause (or causes) of Alzheimer's disease. While a lot of research attention has focused on misfolded proteins as the potential culprit, there have been ...

OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...